EE03046B1 - Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid - Google Patents

Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid

Info

Publication number
EE03046B1
EE03046B1 EE9400441A EE9400441A EE03046B1 EE 03046 B1 EE03046 B1 EE 03046B1 EE 9400441 A EE9400441 A EE 9400441A EE 9400441 A EE9400441 A EE 9400441A EE 03046 B1 EE03046 B1 EE 03046B1
Authority
EE
Estonia
Prior art keywords
angiotensin
formulations
preparation
receptor antagonists
triazolopyrimidine derivatives
Prior art date
Application number
EE9400441A
Other languages
English (en)
Inventor
Bru-Magniez Nicole
G�ngor Timur
Teulon Jean-Marie
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9202109A external-priority patent/FR2687676B1/fr
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of EE03046B1 publication Critical patent/EE03046B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9400441A 1992-02-24 1994-11-22 Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid EE03046B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9202109A FR2687676B1 (fr) 1992-02-24 1992-02-24 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR9205417A FR2687677B1 (fr) 1992-02-24 1992-04-30 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
PCT/FR1993/000161 WO1993017024A1 (fr) 1992-02-24 1993-02-18 Derives de triazolopyrimidines antagonistes des recepteurs a l'angiotensine ii

Publications (1)

Publication Number Publication Date
EE03046B1 true EE03046B1 (et) 1997-10-15

Family

ID=26229283

Family Applications (2)

Application Number Title Priority Date Filing Date
EE9400440A EE03045B1 (et) 1992-02-24 1994-11-22 Angiotensiin II retseptorite antagonistide pürasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid
EE9400441A EE03046B1 (et) 1992-02-24 1994-11-22 Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EE9400440A EE03045B1 (et) 1992-02-24 1994-11-22 Angiotensiin II retseptorite antagonistide pürasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid

Country Status (19)

Country Link
EP (2) EP0628045A1 (et)
JP (2) JP3372040B2 (et)
KR (2) KR100272922B1 (et)
AT (1) ATE179979T1 (et)
AU (2) AU668544B2 (et)
CA (2) CA2128871A1 (et)
CZ (2) CZ204594A3 (et)
DE (1) DE69324910T2 (et)
EE (2) EE03045B1 (et)
ES (1) ES2133390T3 (et)
FI (2) FI943808A (et)
FR (1) FR2687677B1 (et)
HU (2) HU220392B (et)
MD (2) MD553G2 (et)
NZ (2) NZ249508A (et)
RU (1) RU2116308C1 (et)
SK (2) SK99894A3 (et)
TW (2) TW221438B (et)
WO (2) WO1993017023A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
US20080188494A1 (en) * 2005-04-25 2008-08-07 Basf Aktiengesellschaft Use Of 5-Alkyl-6-Phenylalkyl-7-Aminoazolopyrimidines, Novel Azolopyrimidines, Processes For Their Preparation And Compositions Comprising Them
WO2008003753A1 (en) * 2006-07-07 2008-01-10 Biovitrum Ab (Publ) Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
DE102006039255A1 (de) * 2006-08-17 2008-02-21 Bayer Cropscience Ag Insektizide heterocyclische Carbonsäurederivate
PE20120593A1 (es) * 2009-01-30 2012-05-21 Takeda Pharmaceutical Derivados fusionados de pirimidin-4-ona como antagonistas del receptor de angiotensina ii y como agonistas del receptor ppar gamma
US20130252951A1 (en) 2010-09-27 2013-09-26 Proximagen Limited 7-hydroxy-pyrazolo[1,5-a] pyrimidine compounds and their use as ccr2 receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
JPH05505609A (ja) * 1990-03-30 1993-08-19 メルク・エンド・カムパニー・インコーポレーテツド 置換ピリミジン、ピリミジノンおよびピリドリミジン
FR2678618B1 (fr) * 1991-07-05 1993-11-05 Upsa Laboratoires Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
HU9402430D0 (en) 1994-10-28
JPH07504178A (ja) 1995-05-11
FI943807A (fi) 1994-10-24
FI943808A0 (fi) 1994-08-19
AU3635893A (en) 1993-09-13
NZ249508A (en) 1996-07-26
WO1993017024A1 (fr) 1993-09-02
CZ204494A3 (en) 1994-12-15
WO1993017023A1 (fr) 1993-09-02
EE03045B1 (et) 1997-10-15
MD554G2 (ro) 1997-01-31
FR2687677A1 (fr) 1993-08-27
NZ249509A (en) 1996-06-25
HUT70953A (en) 1995-11-28
EP0628046B1 (fr) 1999-05-12
SK99894A3 (en) 1995-04-12
EP0628046A1 (fr) 1994-12-14
EP0628045A1 (fr) 1994-12-14
HU220392B (hu) 2002-01-28
FI943808A (fi) 1994-10-24
AU668139B2 (en) 1996-04-26
CA2128871A1 (en) 1993-09-02
ES2133390T3 (es) 1999-09-16
CZ282075B6 (cs) 1997-05-14
TW221438B (et) 1994-03-01
TW222275B (et) 1994-04-11
MD553G2 (ro) 1996-12-31
FR2687677B1 (fr) 1996-10-11
CA2128876A1 (en) 1993-09-02
SK280343B6 (sk) 1999-12-10
KR950700302A (ko) 1995-01-16
FI943807A0 (fi) 1994-08-19
JP3372040B2 (ja) 2003-01-27
MD554F1 (en) 1996-05-31
KR100272922B1 (ko) 2001-02-01
HU9402429D0 (en) 1994-10-28
DE69324910D1 (de) 1999-06-17
CA2128876C (en) 2004-02-03
AU3635793A (en) 1993-09-13
KR950700303A (ko) 1995-01-16
HUT70949A (en) 1995-11-28
MD553F1 (en) 1996-05-31
JPH07504177A (ja) 1995-05-11
RU94040854A (ru) 1996-08-10
AU668544B2 (en) 1996-05-09
RU2116308C1 (ru) 1998-07-27
ATE179979T1 (de) 1999-05-15
DE69324910T2 (de) 1999-10-21
CZ204594A3 (en) 1994-12-15
SK99794A3 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
NL300006I1 (nl) Imidazolylalkeenzuurderivaten.
NO176049C (no) Analogifremgangsmåte for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-II-reseptorer
CA2072233A1 (en) Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists; processes for preparing them and pharmaceutical compositions containing them
ATE119524T1 (de) Substituierte n-(imidazolyl)alkyl-alanin- derivate.
RU94038256A (ru) Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе
EE03046B1 (et) Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid
FI943730A (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231